SPONSORED

Europe could raise the legal cannabis level

The EU decides to increase the legal THC content to 0.3%.

•• 4 Min
Europe could raise the legal cannabis level

Big day for European hemp farmers and the CBD industry as the approval of THC in industrial hemp has been decided by parliament. Although it is still low compared to countries like Switzerland, this THC limit increase in Europe would certainly loosen it up. A lot is going on in the world of legal cannabis. Sign up for our newsletter to always be up to date.

Hemp farmers in Europe have been pushing for change for some time. The 0.2% THC limit introduced many years ago made it difficult and reduced the number of possible strains. Parliament has now voted to increase this limit to 0.3%, which is foreseen in the reform of the common agricultural policy. But will she actually get through? Where did the 0.2% come from? The first time a standard was set for a European THC limit for industrial hemp was in 1984 when it was set at 0.5%. In the 1970s it was reduced to 0.3%.

At the time, 0.3% was the line separating low-THC hemp (usually high-CBD flowers, but there are also high-CBG strains) and high-THC cannabis. In 1999 this fell back to the previous 0.2%, with the original goal of preventing the cultivation of high-THC marijuana in industrial hemp fields with low-THC levels. The proposal to raise the THC limit is not new and has been going on for quite some time. Before we go any further, it should be noted that between the 1970s when the THC limits were lowered to 0.3% and 1999 when they were further lowered to 0.2%, Europe had 0.3 % THC in hemp worked without massive, adverse problems.

This means that this norm has been in place for at least 20 years, which makes it seem almost silly that it would have to be advocated later, or that an argument against an increase from 0.2% to 0.3% is based on fear negative impact on people or businesses. If this hadn't happened in the more than 20 years of recent history that has been the norm, how would it pass as a legitimate argument now? It also sheds light on this idea that we cannot learn from history or trust it at all. Cannabis has been used for thousands of years, and there is ample evidence of how, when and where cannabis was used. Still, it is mainly treated as if this story is meaningless, with paid research studies being the end result, although often they are not. This inability to learn from history is frustrating, and it becomes all the more apparent how much of a problem it is when Europe argues for not raising a THC limit to a level where it has been working perfectly for years Has.

It should also be noted that while this vote took place almost a week ago, no major publications have yet covered everything. In fact, the only publications covering the news are hemp-related. Why it matters If a person didn't know much about cannabis, they might expect that THC could simply be removed in any percentage. Unfortunately, it doesn't work that way, and different strains of cannabis have different amounts of THC. Not only that, CBD often rises in relation to THC, which means that many strains have been counted because to reach the CBD level, you would have to accept over 0.2% THC. While raising it to 0.3% doesn't mean it's all included, it would mean more strains can be grown. Is that a done deal? Unfortunately not. It is great that Parliament voted, but the decision does not depend on Parliament alone. The policy for passing and / or changing laws in the EU is for three different bodies to approve them or take a decision.

Last week's vote was not about the passing of laws, but simply about defining Parliament's position on the proposed reform of the common agricultural policy. In order for it to actually come into force, two other bodies must agree: the Council of the European Union and the European Commission. The three bodies are scheduled to begin negotiations on the agricultural policy reforms in mid-November. This assumes that questions related to the coronavirus do not force postponements.

It is difficult to say which direction the legislation will go. Europe is more inclined to relax restrictions than other locations, but at the same time it is constantly going back on itself. The inclusion of cannabis extracts in the novel foods category alone was a step backwards, which was only made 1.5 years ago. It may be hard to imagine that Europe is not taking up the agricultural recommendations, but nothing is saying that it doesn't have to either.

So while the European Industrial Hemp Association is looking forward to it, it could happen soon. When it comes to regulating cannabis, things usually don't make sense ... almost everywhere. So if you expect a straight line towards legalization, you are expecting way too much. Perhaps the THC limit in Europe will really be raised. And maybe it won't. But it's just too early to say that.

EuropeCannabislegalization

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.